BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38065408)

  • 1. [Applicability of the Adnex score in predicting the malignancy of ovarian cysts].
    Mekni K; Baba M; Haddad I; Aaraar M; Mejri O; ElFekih C
    Gynecol Obstet Fertil Senol; 2024 Jun; 52(6):398-402. PubMed ID: 38065408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women.
    Nohuz E; De Simone L; Chêne G
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):103-107. PubMed ID: 29709594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.
    Pozzati F; Sassu CM; Marini G; Mascilini F; Biscione A; Giannarelli D; Garganese G; Fragomeni SM; Scambia G; Testa AC; Moro F
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):594-602. PubMed ID: 37204769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China.
    He P; Wang JJ; Duan W; Song C; Yang Y; Wu QQ
    J Ovarian Res; 2021 Dec; 14(1):169. PubMed ID: 34857005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Evaluation of the ADNEX Model for the Prediction of the Ovarian Cancer Risk of Adnexal Masses at Siriraj Hospital.
    Poonyakanok V; Tanmahasamut P; Jaishuen A; Wongwananuruk T; Asumpinwong C; Panichyawat N; Chantrapanichkul P
    Gynecol Obstet Invest; 2021; 86(1-2):132-138. PubMed ID: 33596584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study.
    Van Calster B; Valentin L; Froyman W; Landolfo C; Ceusters J; Testa AC; Wynants L; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Savelli L; Fischerová D; Czekierdowski A; Kaijser J; Coosemans A; Scambia G; Vergote I; Bourne T; Timmerman D
    BMJ; 2020 Jul; 370():m2614. PubMed ID: 32732303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Before surgery predictability of malignant ovarian tumors based on ADNEX model and its use in clinical practice].
    Joyeux E; Miras T; Masquin I; Duglet PE; Astruc K; Douvier S
    Gynecol Obstet Fertil; 2016 Oct; 44(10):557-564. PubMed ID: 27568408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of adnexal mass managed during cesarean section.
    Yu C; Wang J; Lu W; Xie X; Cheng X; Li X
    Adv Clin Exp Med; 2019 Apr; 28(4):447-452. PubMed ID: 30085429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic management of adnexal masses.
    Mettler L; Semm K; Shive K
    JSLS; 1997; 1(2):103-12. PubMed ID: 9876656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses.
    Yuen PM; Yu KM; Yip SK; Lau WC; Rogers MS; Chang A
    Am J Obstet Gynecol; 1997 Jul; 177(1):109-14. PubMed ID: 9240592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions.
    Chen GY; Hsu TF; Chan IS; Liu CH; Chao WT; Shih YC; Jiang LY; Chang YH; Wang PH; Chen YJ
    Eur Radiol; 2022 Nov; 32(11):7854-7864. PubMed ID: 35583711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian masses in young adolescents: imaging findings with surgical confirmation.
    Skiadas VT; Koutoulidis V; Eleytheriades M; Gouliamos A; Moulopoulos LA; Deligeoroglou E; Vlachos L; Kreatsas G
    Eur J Gynaecol Oncol; 2004; 25(2):201-6. PubMed ID: 15032282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance scoring system for assessment of adnexal masses: added value of diffusion-weighted imaging including apparent diffusion coefficient map.
    Hottat NA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):478-487. PubMed ID: 32438461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
    Landolfo C; Ceusters J; Valentin L; Froyman W; Van Gorp T; Heremans R; Baert T; Wouters R; Vankerckhoven A; Van Rompuy AS; Billen J; Moro F; Mascilini F; Neumann A; Van Holsbeke C; Chiappa V; Bourne T; Fischerova D; Testa A; Coosemans A; Timmerman D; Van Calster B
    Br J Cancer; 2024 Apr; 130(6):934-940. PubMed ID: 38243011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses.
    Pereira PN; Sarian LO; Yoshida A; Araújo KG; Barros RHO; Baião AC; Parente DB; Derchain S
    Diagn Interv Radiol; 2018; 24(2):63-71. PubMed ID: 29467113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of ADNEX and IOTA two-step strategy and estimation of risk of complications during follow-up of adnexal masses in low-risk population.
    Pascual MA; Vancraeynest L; Timmerman S; Ceusters J; Ledger A; Graupera B; Rodriguez I; Valero B; Landolfo C; Testa AC; Bourne T; Timmerman D; Valentin L; Van Calster B; Froyman W
    Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
    Wang R; Yang Z
    Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.